Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab
by
Suárez-Cuervo, Carlos
, Coto-Hernández, Rubén
, Mozo-Avellaneda, Lourdes
, Suárez-Díaz, Silvia
, Morán-Castaño, Claudia
, Caminal-Montero, Luis
in
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy
/ Antibodies
/ Antibodies, Antineutrophil Cytoplasmic
/ Antineutrophil cytoplasmic antibodies
/ Autoimmune diseases
/ B-Lymphocytes
/ Coronaviruses
/ Correspondence
/ COVID-19
/ Cytokines
/ Cytotoxicity
/ Disease
/ Humans
/ Immunoglobulin G
/ Infections
/ Patients
/ Pneumonia
/ Remission Induction
/ Rheumatic diseases
/ Rituximab
/ Rituximab - therapeutic use
/ Severe acute respiratory syndrome coronavirus 2
/ Vasculitis
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab
by
Suárez-Cuervo, Carlos
, Coto-Hernández, Rubén
, Mozo-Avellaneda, Lourdes
, Suárez-Díaz, Silvia
, Morán-Castaño, Claudia
, Caminal-Montero, Luis
in
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy
/ Antibodies
/ Antibodies, Antineutrophil Cytoplasmic
/ Antineutrophil cytoplasmic antibodies
/ Autoimmune diseases
/ B-Lymphocytes
/ Coronaviruses
/ Correspondence
/ COVID-19
/ Cytokines
/ Cytotoxicity
/ Disease
/ Humans
/ Immunoglobulin G
/ Infections
/ Patients
/ Pneumonia
/ Remission Induction
/ Rheumatic diseases
/ Rituximab
/ Rituximab - therapeutic use
/ Severe acute respiratory syndrome coronavirus 2
/ Vasculitis
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab
by
Suárez-Cuervo, Carlos
, Coto-Hernández, Rubén
, Mozo-Avellaneda, Lourdes
, Suárez-Díaz, Silvia
, Morán-Castaño, Claudia
, Caminal-Montero, Luis
in
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy
/ Antibodies
/ Antibodies, Antineutrophil Cytoplasmic
/ Antineutrophil cytoplasmic antibodies
/ Autoimmune diseases
/ B-Lymphocytes
/ Coronaviruses
/ Correspondence
/ COVID-19
/ Cytokines
/ Cytotoxicity
/ Disease
/ Humans
/ Immunoglobulin G
/ Infections
/ Patients
/ Pneumonia
/ Remission Induction
/ Rheumatic diseases
/ Rituximab
/ Rituximab - therapeutic use
/ Severe acute respiratory syndrome coronavirus 2
/ Vasculitis
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab
Journal Article
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab
2021
Request Book From Autostore
and Choose the Collection Method
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism,Elsevier Limited
Subject
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy
/ Antibodies, Antineutrophil Cytoplasmic
/ Antineutrophil cytoplasmic antibodies
/ COVID-19
/ Disease
/ Humans
/ Patients
This website uses cookies to ensure you get the best experience on our website.